Preoperative Serum Carcinoembryonic Antigen Level is a Prognostic Factor in Women With Early Non-Small-Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 83, Issue 2, 2007, Pages 419-424

  Hsu, Wen Hu ^a   Huang, Chien Sheng ^a   Hsu, Han Shui ^a   Huang, Wen Jen ^b   Lee, Hui Chen ^a   Huang, Biing Shiun ^a   Huang, Min Hsiung ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER INVASION; CANCER SURVIVAL; DISEASE SEVERITY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; MULTIVARIATE ANALYSIS; PLEURA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PLEURA; PREOPERATIVE CARE; PROGNOSIS; PULMONARY SURGICAL PROCEDURES; RETROSPECTIVE STUDIES;

EID: 33846373650     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.07.079     Document Type: Article

References (29)

1. Annual Report from Department of Health (2004), Executive Yuan, Taiwan
2. Ferguson M.K., Wang J., Hoffman P.C., et al. Sex-associated differences in survival of patients undergoing resection for lung cancer. Ann Thorac Surg 69 (2000) 245-250
3. Minami H., Yoshimura M., Miyamoto Y., Matsuoka H., and Tsubota N. Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer. Chest 118 (2000) 1603-1609
4. De Perrot M., Licker M., Bouchardy C., Usel M., Robert J., and Spiliopoulos A. Sex differences in preservation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg 119 (2000) 21-26
5. Buccheri G., Ferrigno D., and Vola F. Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer. Lung Cancer 10 (1993) 21-33
6. De Angelis G., Bigioni D., Leonatti C., and Pigorini F. Serum carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and neuron specific enolase (NSE) for monitoring lung cancer and correlation with metastases. J Tumor Marker Oncol 3 (1988) 15-20
7. Molina R., Agusti C., Mane J.M., et al. CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels. Int J Biol Markers 9 (1994) 96-101
8. Plebani M., Basso D., Navaglia F., De Paoli M., Tommasini A., and Cipriani A. Clinical evaluation of seven tumor markers in lung cancer diagnosis: can any combination improve the results?. Br J Cancer 72 (1995) 170-173
9. Kimura Y., Fuji T., Hamamoto K., Miyagawa N., Kataoka M., and Iio A. Serum CA125 level is a good prognostic indicator in lung cancer. Br J Cancer 62 (1990) 676-678
10. Ravisalgia, David H., James E.H., Evan P., Anthony E., and Arthur T.S. Role of serum tumor markers Ca 125 and CEA in non-small cell lung cancer. Anticancer Res 21 (2001) 1241-1246
11. Sawabata N., Ohta M., Takeda S., et al. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 74 (2002) 174-179
12. Carcinoembryonic antigen: its role as a marker in the management of cancer. Br Med J (Clin Res Ed) 282 (1981) 373-375
13. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
14. Concannon J.P., Dalbow M.H., Hodgson S.E., et al. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma. Cancer 42 (1978) 1477-1483
15. American Thoracic Society, European Respiratory Society. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 156 (1997) 320-332
16. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, Non-small cell lung cancer-v.2. 2006. Available at: http://www.ncch.org/.
17. Icard P., Regnard J.F., Essomba A., Panebianco V., Magdeleinat P., and Levasseur P. Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 58 (1994) 811-814
18. Okada M., Nishio W., Sakamoto T., et al. Prognostic significance of perioperative serum CEA in NSCLC: analysis of 1000 consecutive resections for clinical stage I disease. Ann Thorac Surg 78 (2004) 216-221
19. Fujishima T., Honda Y., Shijubo N., Takahashi H., and Abe S. Increased carcinoembryonic antigen concentrations in sera and bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Respiration 62 (1995) 317-321
20. Rule A.H., Straus E., Vandevoorde J., and Janowitz H.D. Tumor associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med 287 (1972) 24-26
21. Stevens D.P., and Mackay I.R. Increased carcinoembryonic antigen in heavy cigarette smokers. Lancet 2 (1973) 1238-1239
22. Alexander J.C., Silverman N.A., and Chretien P.B. Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA 235 (1976) 1975-1979
23. Harley Jr. R.A. Tobacco. In: Dail D.H., and Hammar S.P. (Eds). Pulmonary pathology. 2nd ed. (1994), Springer-Verlag, New York 841
24. Liaw Y.P., Huang Y.C., and Lien G.W. Patterns of lung cancer mortality in 23 countries: application of the age-period-cohort model. BMC Public Health 5 (2005) 22
25. Concannon J.P., Dalbow M.H., Hodgson S.E., et al. Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma. Cancer 42 (1978) 1477-1483
26. Padilla J., Calvo V., Penalver J.C., Sales G., and Morcillo J. Surgical results and prognostic factors in early non-small cell lung cancer. Ann Thorac Surg 63 (1997) 324-326
27. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 (1995) 120-129
28. Rena O., Oliaro A., Cavallo A., et al. Stage I non-small cell lung carcinoma: really an early stage?. Eur J Cardiothorac Surg 21 (2002) 514-519
29. The Japan Lung Cancer Society. General rule for clinical and pathological record of lung cancer [In Japanese]. 5th ed. (1999), Kanehara, Tokyo